TY - JOUR
T1 - Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia
AU - Goda, Chinmayee
AU - Kulkarni, Rohan
AU - Bustos, Yaphet
AU - Li, Wenjun
AU - Rudich, Alexander
AU - Balcioglu, Ozlen
AU - Chidester, Sadie
AU - Urs, Amog P.
AU - Karunasiri, Malith
AU - Al-Marrawi, Yzen
AU - Korn, Erin
AU - Kanna, Sanjay
AU - Garfinkle, Elizabeth A.R.
AU - Shah, Nisarg
AU - Wooten, Ashley
AU - Mundy-Bosse, Bethany
AU - Sehgal, Lalit
AU - Zhang, Bin
AU - Marcucci, Guido
AU - Mardis, Elaine R.
AU - Garzon, Ramiro
AU - Bowman, Robert L.
AU - Viny, Aaron D.
AU - Miles, Linde A.
AU - Miller, Katherine E.
AU - Dorrance, Adrienne
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Leukemias arise from recurrent clonal mutations in hematopoietic stem/progenitor cells (HSPCs) that cause profound changes in the bone marrow microenvironment (BMM) favoring leukemic stem cell (LSC) growth over normal HSPCs. Understanding the cross talk between preleukemic mutated HSPCs and the BMM is critical to develop novel therapeutic strategies to prevent leukemogenesis. We hypothesize that preleukemic-LSCs (pLSCs) induce BMM changes critical for leukemogenesis. Using our AML-murine model, we performed single-cell RNA-sequencing of preleukemic BMM (pBMM) cells. We found normal HSC (nHSC)-regulating LepR+ mesenchymal stem cells, and endothelial cells were decreased, along with increases in CD55+ fibroblasts and pericytes. Preleukemic CD55+ fibroblasts had higher proliferation rates and decreased collagen expression, suggesting extracellular matrix remodeling during leukemogenesis. Importantly, co-culture assays found preleukemic CD55+ fibroblasts expanded pLSCs significantly over nHSCs. In conclusion, we have identified a distinct pBMM and a novel CD55+ fibroblast population that is expanded in pBMM that promote fitness of pLSCs over nHSCs.
AB - Leukemias arise from recurrent clonal mutations in hematopoietic stem/progenitor cells (HSPCs) that cause profound changes in the bone marrow microenvironment (BMM) favoring leukemic stem cell (LSC) growth over normal HSPCs. Understanding the cross talk between preleukemic mutated HSPCs and the BMM is critical to develop novel therapeutic strategies to prevent leukemogenesis. We hypothesize that preleukemic-LSCs (pLSCs) induce BMM changes critical for leukemogenesis. Using our AML-murine model, we performed single-cell RNA-sequencing of preleukemic BMM (pBMM) cells. We found normal HSC (nHSC)-regulating LepR+ mesenchymal stem cells, and endothelial cells were decreased, along with increases in CD55+ fibroblasts and pericytes. Preleukemic CD55+ fibroblasts had higher proliferation rates and decreased collagen expression, suggesting extracellular matrix remodeling during leukemogenesis. Importantly, co-culture assays found preleukemic CD55+ fibroblasts expanded pLSCs significantly over nHSCs. In conclusion, we have identified a distinct pBMM and a novel CD55+ fibroblast population that is expanded in pBMM that promote fitness of pLSCs over nHSCs.
UR - http://www.scopus.com/inward/record.url?scp=85205428053&partnerID=8YFLogxK
U2 - 10.1038/s41375-024-02415-3
DO - 10.1038/s41375-024-02415-3
M3 - Article
C2 - 39358541
AN - SCOPUS:85205428053
SN - 0887-6924
JO - Leukemia
JF - Leukemia
ER -